11.5(top 1%)
Impact Factor
12.9(top 1%)
extended IF
180(top 1%)
H-Index
1,762
authors
8,371
papers
265,014
citations
9,783
citing journals
112,398
citing authors

Most Cited Articles of Drugs in 1988

TitleYearCitations
Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy1988346
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use1988261
Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence1988222
Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential1988215
Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic1988200
Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders1988178
Current concepts in the treatment of disorders of micturition1988161
Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia1988118
Flumazenil. A preliminary review of its benzodiazepine antagonist properties, intrinsic activity and therapeutic use1988117
Lovastatin. A preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidaemia1988114
Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use1988113
Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure198899
Quazepam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in insomnia198893
Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer198890
Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease198888
Sufentanil. A review of its pharmacological properties and therapeutic use198883
Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study198882
Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension198879
Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative198878
Milrinone. A preliminary review of its pharmacological properties and therapeutic use198876
Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure198876
Drug interactions that matter. A critical reappraisal198875
Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration198873
Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension198871
Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states198869